N-(4-fluorophenyl)benzo[d]thiazol-2-amine
CAS No. 348-45-8
N-(4-fluorophenyl)benzo[d]thiazol-2-amine( —— )
Catalog No. M28897 CAS No. 348-45-8
N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 44 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 79 | In Stock |
|
| 25MG | 166 | In Stock |
|
| 50MG | 230 | In Stock |
|
| 100MG | 334 | In Stock |
|
| 200MG | 455 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-(4-fluorophenyl)benzo[d]thiazol-2-amine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
-
DescriptionN-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCYP17
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number348-45-8
-
Formula Weight244.29
-
Molecular FormulaC13H9FN2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (511.69 mM)
-
SMILESFc1ccc(Nc2nc3ccccc3s2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang M, et al. Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors. Eur J Med Chem. 2017 May 26;132:157-172.
molnova catalog
related products
-
Baohuoside V
Baohuoside V is a natural product.
-
Gelsemine
Gelsemine has marked antinociception in inflammatory, neuropathic and bone cancer pains without inducing antinociceptive tolerance.
-
MW01-2-151SRM
MW01-2-151SRM is a novel small molecule inhibitor of microglia activation that crosses the blood-brain barrier, has anti-neuroinflammatory effects, attenuates the up-regulation of glial cytokines in models of neuroinflammation, and can be used in studies of traumatic brain injury, Alzheimer's disease, and alginate toxicity.
Cart
sales@molnova.com